Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 677-688

  Glavan, T W ^a   Gaulke, C A ^a,e   Santos Rocha, C ^a   Sankaran Walters, S ^a   Hirao, L A ^a   Raffatellu, M ^b   Jiang, G ^a   Baumler A J ^a   Goulart, L R ^a,c   Dandekar, S ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACTINOBACILLUS; AGGREGATIBACTER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DYSBIOSIS; EARLY INTERVENTION; GENE EXPRESSION; GUT IMMUNE DYSFUNCTION; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; MYCOPLASMATACEAE; NONHUMAN; PASTEURELLACEAE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T CELL DEPLETION; VIRAL CLEARANCE; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUCOSAL IMMUNITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CHRONIC DISEASE; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, MUCOSAL; MACACA MULATTA; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 8; VIRAL LOAD; VIRUS REPLICATION;

EID: 84964938421     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.92     Document Type: Article

References (50)

1. Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003).
2. Moir, S., Chun, T.W. & Fauci, A.S. Pathogenic mechanisms of HIV disease. Annu. Rev. Pathol. 6, 223-248 (2011).
3. Dandekar, S., George, M.D. & Baumler, A.J. Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173-178 (2010).
4. Sankaran, S. et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82, 538-545 (2008).
5. Maartens, G., Celum, C. & Lewin, S.R. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 384, 258-271 (2014).
6. Guadalupe, M. et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80, 8236-8247 (2006).
7. Klatt, N.R., Funderburg, N.T. & Brenchley, J.M. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 21, 6-13 (2013).
8. Deeks, S.G. et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942-947 (2004).
9. Keedy, K.S. & Margolis, D.M. Therapy for persistent HIV. Trends Pharmacol. Sci. 31, 206-211 (2010).
10. Macal, M. et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1, 475-488 (2008).
11. Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra191 (2013).
12. Mutlu, E.A. et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 10, e1003829 (2014).
13. Lozupone, C.A. et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 14, 329-339 (2013).
14. Brestoff, J.R. & Artis, D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14, 676-684 (2013).
15. Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gutmicrobiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599-608 (2012).
16. Dillon, S.M. et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7, 983-994 (2014).
17. Klase, Z. et al. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol. 8, 1009-1020 (2015).
18. Ocon, S. et al. Transcription profiling reveals potential mechanisms of dysbiosis in the oral microbiome of rhesus macaques with chronic untreated SIV infection. PLoS One 8, e80863 (2013).
19. Moeller, A.H. et al. SIV-induced instability of the chimpanzee gut microbiome. Cell Host Microbe 14, 340-345 (2013).
20. Verhoeven, D., Sankaran, S., Silvey, M. & Dandekar, S. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory Tcells. J. Virol. 82, 4016-4027 (2008).
21. Marthas, M.L. et al. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18, 311-319 (1989).
22. Lackner, A.A., Vogel, P., Ramos, R.A., Kluge, J.D. & Marthas, M. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145, 428-439 (1994).
23. George, M.D., Reay, E., Sankaran, S. & Dandekar, S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J. Virol. 79, 2709-2719 (2005).
24. Wang, Y., Wang, X., Li, J., Zhou, Y. & Ho, W. RIG-I activation inhibits HIV replication in macrophages. J. Leukoc. Biol. 94, 337-341 (2013).
25. Buitendijk, M., Eszterhas, S.K. & Howell, A.L. Toll-like receptor agonists are potent inhibitors of human immunodeficiency virus-type 1 replication in peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 30, 457-467 (2014).
26. Fives-Taylor, P.M., Meyer, D.H., Mintz, K.P. & Brissette, C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontology 2000 20, 136-167 (1999).
27. Sankaran, S. et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 102, 9860-9865 (2005).
28. Raffatellu, M. et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421-428 (2008).
29. Veazey, R.S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
30. Smit-McBride, Z.,Mattapallil, J.J., McChesney,M., Ferrick, D. & Dandekar, S. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72, 6646-6656 (1998).
31. Verhoeven, D. et al. Enhanced innate antiviral gene expression, IFN-alpha, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection. J. Immunol. 192, 3308-3318 (2014).
32. Heise, C., Vogel, P., Miller, C.J., Halsted, C.H. & Dandekar, S. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 142, 1759-1771 (1993).
33. Brubaker, S.W., Bonham, K.S., Zanoni, I. & Kagan, J.C. Innate immune pattern recognition: A cell biological perspective. Annu. Rev. Immunol. 33, 257-290 (2015).
34. Sang, M., Liu, J.B., Dai, M., Wu, J.G. & Ho, W.Z. Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques. Antiviral Res. 112, 103-112 (2014).
35. Dominguez-Villar, M., Gautron, A.S., de Marcken,M., Keller, M.J. & Hafler, D.A. TLR7 induces anergy in human CD4(+) T cells. Nat. Immunol. 16, 118-128 (2015).
36. Hirao, L.A. et al. Early mucosal sensing of SIV infection by paneth cells induces IL-1beta production and initiates gut epithelial disruption. PLoS Pathog. 10, e1004311 (2014).
37. Ben Haij, N. et al. HIV-1 tat protein induces production of proinflammatory cytokines by human dendritic cells and monocytes/macrophages through engagement of TLR4-MD2-CD14 complex and activation of NF-kappaB pathway. PLoS One 10, e0129425 (2015).
38. Bosinger, S.E. et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 119, 3556-3572 (2009).
39. Gringhuis, S.I. et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 11, 419-426 (2010).
40. Ellegard, R. et al. Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J. Immunol. 193, 4590-4601 (2014).
41. McGowan, I., Radford-Smith, G. & Jewell, D.P. Cytokine gene expression in HIV-infected intestinal mucosa. Aids 8, 1569-1575 (1994).
42. Nagy, L.H. et al. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS One 8, e72789 (2013).
43. Mogensen, T.H., Melchjorsen, J., Larsen, C.S. & Paludan, S.R. Innate immune recognition and activation during HIV infection. Retrovirology 7, 54 (2010).
44. Whitney, J.B. et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512, 74-77 (2014).
45. Stone, J.D., Heise, C.C., Canfield, D.R., Elices, M.J. & Dandekar, S. Differences in viral distribution and cell-adhesion molecule expression in the intestinal-tract of rhesus macaques infected with pathogenic and nonpathogenic SIV. J. Med. Primatol. 24, 132-140 (1995).
46. Kristoff, J. et al. Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. J. Clin. Invest. 124, 2802-2806 (2014).
47. Sandler, N.G. et al. Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. J. Infect. Dis. 210, 1549-1554 (2014).
48. Winter, S.E., Lopez, C.A. & Baumler, A.J. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 14, 319-327 (2013).
49. Round, J.L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977 (2011).
50. Edwards, L.A. et al. Enterotoxin-producing staphylococci cause intestinal inflammation by a combination of direct epithelial cytopathy and superantigen-mediated T-cell activation. Inflamm. Bowel Dis. 18, 624-640 (2012).